| Systematic (IUPAC) name | |
|---|---|
| (3R,5R,6S,7R,8R,11R,12S,13R,14S,15S)-14-((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6-hydroxy-12-((2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yloxy)-5,7,8,11,13,15-hexamethyl-1,9-dioxaspiro[2.13]hexadecane-4,10-dione | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 3922-90-5 |
| ATC code | J01FA05 |
| PubChem | CID 5284598 |
| ChemSpider | 4447646 |
| UNII | P8ZQ646136 |
| Chemical data | |
| Formula | C35H61NO12 |
| Mol. mass | 687.858 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| (what is this?) (verify) |
|
Oleandomycin is a macrolide antibiotic. It is synthesized from strains of Streptomyces antibioticus. It is weaker than erythromycin.
It used to be sold under the brand name Sigmamycine, combined with Tetracycline, and made by the company Rosa-Phytopharma in France.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||